GSK_ Annual_Report

69 OTHER DISCLOSURES Transactions with related parties are disclosed in Note 53 to the standalone financial statements in the Annual Report. Company has not obtained any credit rating for the financial year ended 31 March 2022. Company has not raised any funds through preferential allotment or QIP for the financial year ended 31 March 2022. Company has paid ` 1,21.50 lakhs as total fees for all services provided by Deloitte Haskins & Sells LLP, Statutory Auditors of the Company. Policy for related party transactions has been uploaded on the Company’s website (https:// india-pharma.gsk.com/en-in/investors/shareholder- information/policies/ ) . During the year, your Company received two sexual harassment complaints & two sexual harassment complaints were already under investigation. All four complaints have been closed. During the last three years, there were no strictures or penalties imposed by either the Securities and Exchange Board of India or the Stock Exchanges or any statutory authority for non-compliance of any matter related to the capital markets. The Codes of Conduct applicable to all Directors and employees of the Company have been posted on the Company’s website. For the year under review, all Directors and Senior Management personnel of the Company have confirmed their adherence to the provisions of the said Codes. The Company has put in place a whistle blower policy/ vigil mechanism pursuant to which employees of the Company can raise their concerns relating to fraud, malpractice or any other activity or event which is against the interest of the Company and no one has been denied access to the Audit Committee. The Company has in place Risk Management Policy for Risk Assessment and Mitigation and it is periodically reviewed by the Board Members. The Company is not dealing in commodity and hence disclosure pursuant to SEBI Circular dated 15 November 2018 is not required to be given. There is no Non-Compliance of any requirement of Corporate Governance Report of Sub para (2) to (10) of Part C of Schedule V of the Listing Regulations. The Company has complied with all mandatory items of the Regulations 17 to 27 and clauses (b) to (i), (t) of sub-regulation (2) of the regulation 46 with schedule II and V of Listing Regulations. NON-MANDATORY REQUIREMENTS A. The Board The Chairman of the Board does not maintain a Chairman’s office at the Company’s expense. B. Shareholders’ Right The quarterly and half-yearly results are published in widely circulating national and local dailies such as The Economic Times and Business Standard, in English, and Maharashtra Times, in Marathi. These are not sent individually to the shareholders but hosted on the website of the Company. C. Audit Qualification There are no qualifications contained in the Audit Report. D. Separate post of Chairman and Managing Director The posts of Chairman and Managing Director are separate. E. Reporting of Internal Auditors The Internal Auditor of the Company reports to the Audit Committee and makes detailed presentations at quarterly meetings. On behalf of the Board of Directors Ms. R. S. Karnad Mumbai, 16 May 2022 Chairperson

GSK_ Annual_Report_2021-22